Status:
ACTIVE_NOT_RECRUITING
A Biomarker Exploration Study of Precision Treatment in Ovarian Cancer
Lead Sponsor:
Tongji Hospital
Conditions:
Ovarian Cancer
Biomarker
Eligibility:
FEMALE
18-80 years
Brief Summary
This clinical trial aims to investigate the role of biomarkers in guiding precision treatment for ovarian cancer. The study will explore the effectiveness of personalized treatment strategies based on...
Eligibility Criteria
Inclusion
- Patients diagnosed with ovarian cancer.
- Willingness to undergo biomarker testing.
- Ability to provide informed consent for participation in the study.
Exclusion
- Inability to comply with study requirements or follow-up visits.
- Previous participation in a conflicting clinical trial.
Key Trial Info
Start Date :
March 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT06483425
Start Date
March 1 2024
End Date
December 1 2028
Last Update
July 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China, 430030